| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668360 | Journal of Clinical Lipidology | 2018 | 5 Pages |
Abstract
Two months of treatment with evolocumab 140Â mg may improve endothelial function in subjects with increased cardiovascular risk. The improvement in endothelial function is proportional to LDL reduction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Guglielmo MD, Francesco MD, Dolores MD, Grazia MD, Carlo MD, Luigi MD, Antonio MD, Matteo MD, Natale Daniele MD, PhD,